Stay updated with breaking news from Culmination Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company
Merck has signed a R&D collaboration deal with data and technology company Culmination Bio, a spinoff from Intermountain Health.
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced an R&D collaboration with Merck, known as MSD, outside the United States and Canada, initially in the area of autoimmune disease.